Cited by 418Pharmacogenetics and Drug MetabolismDiabetes Treatment and ManagementMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Accumulation of metformin by tissues of the normal and diabetic mouse

Wilcock, C., Bailey, C. J.·1994·Xenobiotica

Open this paper in CoChat — free account

Abstract

1. Tissue accumulation of the antihyperglycaemic agent metformin (dimethylbiguanide) was examined after oral administration to the normal and streptozotocin (STZ) diabetic mouse. 2. Metformin (50 mg/kg body weight containing 14C-metformin 25 microCi/kg body weight), which is stable and not metabolized, resulted in maximum plasma concentrations at 0.5 h which declined to < 5% of maximum by 24 h. Maximum plasma concentrations (mumol/l, mean +/- SE) in the hepatic portal vein (normal 51.7 +/- 5.4, STZ 61.5 +/- 8.0) were higher than in the inferior vena cava (normal 29.0 +/- 2.8, STZ 35.4 +/- 5.9). 3. The greatest accumulation of metformin occurred in tissues of the small intestine, where maximum concentrations were > 1000 mumol/kg wet weight at 0.5-2 h, but declined to < 2% of maximum by 24 h. 4. Stomach, colon, salivary gland, kidney and liver accumulated metformin more than two-fold, and concentrations of the drug in heart and skeletal (gastrocnemius) muscle were greater than plasma concentrations on some occasions up to 8 h. 5. In a separate study, i.v.-administered metformin was selectively accumulated by tissues of the small intestine. Thus, retention of metformin by tissues of the small intestine may represent a deep compartment for the drug.

Integrity signals

Registry

Crossref · 10.3109/00498259409043220

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Verapamil
Singh, B. N., Ellrodt, G. A., & Peter, C. T. (1978) · Drugs · doi:10.2165/00003495-197815030-00001 · Cited by 835
Biguanides and NIDDM
Bailey, C. J. (1992) · Diabetes Care · doi:10.2337/diacare.15.6.755 · Cited by 593
Self-citation
Metformin kinetics in healthy subjects and in patients with diabetes mellitus.
Tucker, G., Casey, C., Phillips, P., Connor, H., Ward, J. D., & Woods, H. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01206.x · Cited by 503
Pharmacokinetics of Metformin After Intravenous and Oral Administration to Man
Pentik�inen, P. J., Neuvonen, P. J., & Penttil�, A. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562061 · Cited by 348
Disposition of metformin (N,N‐dimethylbiguanide) in man
Sirtori, C. R., Franceschini, G., Galli-Kienle, M., Cighetti, G., Galli, G., Bondioli, A., & Conti, F. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1978246683 · Cited by 222
Metformin: a review of its pharmacological properties and therapeutic use.
Ls, H. (1979) · PubMed · Cited by 175
Determination of glucose by an automatic analyser
Stevens, J. F. (1971) · Clinica Chimica Acta · doi:10.1016/0009-8981(71)90332-9 · Cited by 166
Gastrointestinal Motility.
Konturek, S. J. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-5-789_4 · Cited by 158
Effect of metformin on glucose metabolism in the splanchnic bed
Bailey, C. J., Wilcock, C., & Day, C. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09093.x · Cited by 131
Self-citation
Metformin in the digestive tract
Vidon, N., Chaussade, S., Noël, M., Franchisseur, C., Huchet, B., & Bernier, J. J. (1988) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(88)80022-6 · Cited by 117

Flagged first, then by citations

Show all 23 references

Research works printed but not linked: 7

Bailey C. J., 1988, Balliere's Clinical Endocrinology and Metabolism, 2, 455
Bailey C. J., 1986, Diabete et Metabolisme, 12, 212
Cigolini M., 1984, Diabete et Metabolisme, 10, 311
Cohen P. Y., 1961, Therapie, 16, 109
Hermann L. S, 1979, Diabete et Metabolisme, 5, 233
Mordes J. P., 1985, Joslin's Diabetes Mellitus12th edn, 110
Noel M, 1979, Research and Clinical Forums, 1, 35

Sorted by citations

Items 101–200 of 414

Metformin combined with aspirin significantly inhibit pancreatic cancer cell growthin vitroandin vivoby suppressing anti-apoptotic proteins Mcl-1 and Bcl-2
Yue, W., Zheng, X., Lin, Y., Yang, C. S., Xu, Q., Carpizo, D. R., Huang, H., DiPaola, R. S., & Tan, X. (2015) · Oncotarget · doi:10.18632/oncotarget.4126 · Cited by 95
Metformin: New Preparations and Nonglycemic Benefits
Fujita, Y., & Inagaki, N. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0829-8 · Cited by 91
Lactic Acidosis in Metformin Therapy
Lalau, J., & Race, J. (1999) · Drugs · doi:10.2165/00003495-199958001-00013 · Cited by 94
Metformin's antitumour and anti‐angiogenic activities are mediated by skewing macrophage polarization
Wang, J., Sun, X., Ma, Q., Fu, G., Cong, L., Zhang, H., Fan, D., Feng, J., Lu, S., Liu, J., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13655 · Cited by 92
Metformin treatment significantly enhances intestinal glucose uptake in patients with type 2 diabetes: Results from a randomized clinical trial
Koffert, J., Mikkola, K., Virtanen, K. A., Andersson, A. D., Faxius, L., Hällsten, K., Heglind, M., Guiducci, L., Pham, T. T., Silvola, J. M. U., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.07.015 · Cited by 91
Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight
Zhang, S., Bruce, K., Danaei, Z., Li, R. J. W., Barros, D. R., Kuah, R., Lim, Y.-M., Mariani, L. H., Cherney, D. Z. I., Chiu, J. F. M., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.03.014 · Cited by 92
Two weeks of metformin treatment induces AMPK-dependent enhancement of insulin-stimulated glucose uptake in mouse soleus muscle
Kristensen, J. M., Treebak, J. T., Schjerling, P., Goodyear, L. J., & Wojtaszewski, J. F. P. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00417.2013 · Cited by 89
Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice
Allard, J. S., Perez, E. J., Fukui, K., Carpenter, P., Ingram, D. K., & Cabo, R. D. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.012 · Cited by 88
Metformin Selectively Targets Tumor-Initiating Cells in ErbB2-Overexpressing Breast Cancer Models
Zhu, P. H., Davis, M. B., Blackwelder, A. J., Bachman, N., Liu, B., Edgerton, S. M., Williams, L. L., Thor, A. D., & Yang, X. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0181 · Cited by 87
In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma
Luo, Q., Hu, D., Hu, S., Yan, M., Sun, Z., & Chen, F. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-517 · Cited by 87
Metformin promotes isolated rat liver mitochondria impairment
Carvalho, C., Correia, S. C., Santos, M. S., Seiça, R. M. F., Oliveira, C. R., & Moreira, P. I. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9614-3 · Cited by 88
Taste of a Pill
Lee, N., Duan, H., Hébert, M. F., Liang, C., Rice, K. M., & Wang, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.570564 · Cited by 88
Effect of metformin on advanced glycation endproduct formation and peripheral nerve function in streptozotocin-induced diabetic rats
Tanaka, Y., Uchino, H., Shimizu, T., Yoshii, H., Niwa, M., Ohmura, C., Mitsuhashi, N., Onuma, T., & Kawamori, R. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00342-8 · Cited by 85
Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism
Alshawi, A., & Agius, L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006670 · Cited by 87
Response of Breast Cancer Cells and Cancer Stem Cells to Metformin and Hyperthermia Alone or Combined
Lee, H., Park, H. J., Park, C., Oh, E., Choi, B.-H., Williams, B. W., Lee, C. K. K., & Song, C. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087979 · Cited by 84
Retracted
The Antidiabetic Drug Metformin Inhibits the Proliferation of Bladder Cancer Cells in Vitro and in Vivo
Zhang, T., Guo, P., Zhang, Y., Xiong, H., Yu, X., Xu, S., Wang, X., He, D., & Jin, X. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141224603 · Cited by 84
Metformin Suppresses Expression of the Selenoprotein P Gene via an AMP-activated Kinase (AMPK)/FoxO3a Pathway in H4IIEC3 Hepatocytes
Takayama, H., Misu, H., Iwama, H., Chikamoto, K., Saito, Y., Murao, K., Teraguchi, A., Lan, F., Kikuchi, A., Saito, R., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.479386 · Cited by 82
Metformin-Treated Patients With Type 2 Diabetes Have Normal Mitochondrial Complex I Respiration
Larsen, S., Rabøl, R., Hansen, C. N., Madsbad, S., Helge, J. W., & Dela, F. (2012) · Diabetologia · doi:10.1007/s00125-011-2340-0 · Cited by 81
Metabolic Action of Metformin
Szymczak-Pajor, I., Wenclewska, S., & Śliwińska, A. (2022) · Pharmaceuticals · doi:10.3390/ph15070810 · Cited by 89
A combined in vitro approach to improve the prediction of mitochondrial toxicants
Eakins, J. A., Bauch, C., Woodhouse, H. J., Park, B. J., Bevan, S. J., Dilworth, C., & Walker, P. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.03.016 · Cited by 79
Metformin acts in the gut and induces gut-liver crosstalk
Tobar, N., Rocha, G. Z., Santos, A., Guadagnini, D., Assalin, H. B., de Camargo, J. A., Gonçalves, A. E. S. S., Pallis, F. R., Oliveira, A. G., Rocco, S. A., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211933120 · Cited by 81
Antiproliferative action of metformin in human lung cancer cell lines
Takiguchi, Y. (2012) · Oncology Reports · doi:10.3892/or.2012.1763 · Cited by 79
Effects of metformin hydrochloride on blood glucose and insulin responses to oral dextrose in horses
Rendle, D. I., Rutledge, F., Hughes, K., Heller, J., & Durham, A. E. (2013) · Equine Veterinary Journal · doi:10.1111/evj.12068 · Cited by 82
Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: A multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
Morgillo, F., Fasano, M., Della Corte, C. M., Sasso, F. C., Papaccio, F., Viscardi, G., Esposito, G., Di Liello, R., Normanno, N., Capuano, A., et al. (2017) · ESMO Open · doi:10.1136/esmoopen-2016-000132 · Cited by 76
Severe metformin intoxication with lactic acidosis in an adolescent
Lacher, M., Hermanns‐Clausen, M., Häeffner, K., Brandis, M., & Pöhl, M. (2005) · European Journal of Pediatrics · doi:10.1007/s00431-005-1634-y · Cited by 76
Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice
Fielder, E., Wan, T., Alimohammadiha, G., Ishaq, A., Low, E., Weigand, B. M., Kelly, G., Parker, C., Griffin, B., Jurk, D., et al. (2022) · eLife · doi:10.7554/elife.75492 · Cited by 76
The Mechanism of Action of Biguanides: New Answers to a Complex Question
Magno, L. D., Pastena, F. D., Bordone, R., Coni, S., & Canettieri, G. (2022) · Cancers · doi:10.3390/cancers14133220 · Cited by 81
Clearance of the high intestinal 18F-FDG uptake associated with metformin after stopping the drug
Özülker, T., Özülker, F., Mert, M., & Özpaçacı, T. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1330-7 · Cited by 75
Glucose and Metformin Modulate Human First Trimester Trophoblast Function: a Model and Potential Therapy for Diabetes‐Associated Uteroplacental Insufficiency
Han, C. S., Herrin, M. A., Pitruzzello, M. C., Mulla, M. J., Werner, E. F., Pettker, C. M., Flannery, C. A., & Abrahams, V. M. (2014) · American Journal of Reproductive Immunology · doi:10.1111/aji.12339 · Cited by 75
Live cell imaging of mouse intestinal organoids reveals heterogeneity in their oxygenation
Okkelman, I. A., Foley, T., Papkovsky, D. B., & Dmitriev, R. I. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.08.043 · Cited by 74
Variation in the Plasma Membrane Monoamine Transporter (PMAT) (Encoded by SLC29A4 ) and Organic Cation Transporter 1 (OCT1) (Encoded by SLC22A1 ) and Gastrointestinal Intolerance to Metformin in Type 2 Diabetes: An IMI DIRECT Study
Dawed, A. Y., Zhou, K., van Leeuwen, N., Mahajan, A., Robertson, N., Koivula, R. W., Elders, P. J. M., Rauh, S. P., Jones, A. G., Holl, R. W., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2182 · Cited by 74
Measurement of metformin concentration in erythrocytes:clinical implications
Lalau, J., & Lacroix, C. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00241.x · Cited by 74
Pharmacodynamic Aspects of Modes of Drug Administration for Optimization of Drug Therapy
Hoffman, A., & Stepensky, D. (1999) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v16.i6.20 · Cited by 73
Metformin selectively dampens the acute inflammatory response through an AMPK-dependent mechanism
Postler, T. S., Peng, V., Bhatt, D. M., & Ghosh, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-97441-x · Cited by 73
Metformin-induced regulation of the intestinal D-glucose transporters.
Sakar, Y., Meddah, B., Faouzi, M. A., Cherrah, Y., Bado, A., & Ducroc, R. A. (2010) · PubMed · Cited by 72
A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer
Khan, A., & Frigo, D. E. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2016.272 · Cited by 74
Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor
Kato, H., Sekine, Y., Furuya, Y., Miyazawa, Y., Koike, H., & Suzuki, K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.178 · Cited by 71
Disposition of metformin: Variability due to polymorphisms of organic cation transporters
Zolk, O. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.549144 · Cited by 71
Metformin: A Candidate Drug for Renal Diseases
Corremans, R., Vervaet, B. A., D’Haese, P. C., Neven, E., & Verhulst, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010042 · Cited by 71
Metformin, Cognitive Function, and Changes in the Gut Microbiome
Rosell-Díaz, M., & Fernández‐Real, J. M. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad029 · Cited by 68
The antiviral effect of metformin on zika and dengue virus infection
Farfán-Morales, C. N., Cordero‐Rivera, C. D., Osuna‐Ramos, J. F., Monroy-Muñoz, I. E., Jesús‐González, L. A. D., Muñoz‐Medina, J. E., Hurtado-Monzón, A. M., Reyes-Ruíz, J. M., & del Ángel, R. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-87707-9 · Cited by 67
Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies
Amengual-Cladera, E., Morla-Barcelo, P. M., Morán-Costoya, A., Valle, A., Pons, D. G., Sastre‐Serra, J., Roca, P., & Nadal‐Serrano, M. (2024) · Biology · doi:10.3390/biology13050302 · Cited by 74
Metformin and trametinib have synergistic effects on cell viability and tumor growth inNRASmutant cancer
Vujic, I., Sanlorenzo, M., Posch, C., Esteve‐Puig, R., Yen, A., Kwong, A., Tsumura, A., Murphy, R. M., Rappersberger, K., & Ortiz‐Urda, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2824 · Cited by 66
Cardiovascular impact of drugs used in the treatment of diabetes
Triggle, C. R., & Ding, H. (2014) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622314546125 · Cited by 67
Dual Effects of Metformin on Adipogenic Differentiation of 3T3-L1 Preadipocyte in AMPK-Dependent and Independent Manners
Chen, D., Wang, Y., Wu, K., & Wang, X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061547 · Cited by 66
Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?
Malaguarnera, R., Vella, V., Nicolosi, M. L., & Belfiore, A. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00314 · Cited by 68
New Molecules and Old Drugs as Emerging Approaches to Selectively Target Human Glioblastoma Cancer Stem Cells
Würth, R., Barbieri, F., & Florio, T. (2014) · BioMed Research International · doi:10.1155/2014/126586 · Cited by 69
New Insights Into the Anti-Diabetic Actions of Metformin: From the Liver to the Gut
Wu, T., Horowitz, M., & Rayner, C. K. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1273769 · Cited by 64
Metformin overdose, but not lactic acidosis per se, inhibits oxygen consumption in pigs
Protti, A., Fortunato, F., Monti, M., Vecchio, S., Gatti, S., Comi, G. P., Giuseppe, R. D., & Gattinoni, L. (2012) · Critical Care · doi:10.1186/cc11332 · Cited by 64
Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures
Łabuzek, K., Liber, S., Gabryel, B., & Okopień, B. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70343-1 · Cited by 64
Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide’s antiproliferative effect
Karpel‐Massler, G., Kast, R. E., Westhoff, M., Dwucet, A., Welscher, N. E., Nonnenmacher, L., Hlaváč, M., Siegelin, M. D., Wirtz, C. R., Debatin, K., et al. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1688-7 · Cited by 63
Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-α or isoproterenol
Ren, T., He, J., Jiang, H., Zu, L., Pu, S., Guo, X., & Xu, G. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02061 · Cited by 63
Effects of imeglimin on mitochondrial function, AMPK activity, and gene expression in hepatocytes
Hozumi, K., Sugawara, K., Ishihara, T., Ishihara, N., & Ogawa, W. (2023) · Scientific Reports · doi:10.1038/s41598-023-27689-y · Cited by 62
Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice
Xue, Y., Zhang, H., Sun, X., & Zhu, M.-J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0168670 · Cited by 61
Metformin Alters Locomotor and Cognitive Function and Brain Metabolism in Normoglycemic Mice
Li, W., Chaudhari, K., Shetty, R. A., Winters, A., Gao, X., Hu, Z., Ge, W., Sumien, N., Forster, M. J., Liu, R., et al. (2019) · Aging and Disease · doi:10.14336/ad.2019.0120 · Cited by 61
The evidence of metabolic-improving effect of metformin in Ay/a mice with genetically-induced melanocortin obesity and the contribution of hypothalamic mechanisms to this effect
Derkach, K. V., Zakharova, I. O., Zorina, I. I., Bakhtyukov, A. A., Romanova, I. V., Bayunova, L. V., & Shpakov, A. O. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213779 · Cited by 60
In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors
Barbieri, F., Thellung, S., Ratto, A., Carra, E., Marini, V., Fucile, C., Bajetto, A., Pattarozzi, A., Würth, R., Gatti, M., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1235-8 · Cited by 61
Metformin and erlotinib synergize to inhibit basal breast cancer
Lau, Y.-K. I., Du, X., Rayannavar, V., Hopkins, B. D., Shaw, J. M., Bessler, E., Thomas, T. A., Pires, M. M., Keniry, M. E., Parsons, R. E., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2391 · Cited by 58
Pharmacokinetics of metformin in patients with gastrointestinal intolerance
MCCREIGHT, L. J., Stage, T. B., Connelly, P. J., Lonergan, M. E., Nielsen, F., Prehn, C. P., Adamski, J., Brøsen, K., & Pearson, E. R. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13264 · Cited by 59
Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control
Antognelli, C., Cecchetti, R., Riuzzi, F., Peirce, M. J., & Talesa, V. N. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13581 · Cited by 58
Impact of metformin on reproductive tissues: an overview from gametogenesis to gestation.
Bertoldo, M. J., Faure, M., Dupont, J., & Froment, P. (2014) · PubMed Central · doi:10.3978/j.issn.2305-5839.2014.06.04 · Cited by 59
Metformin-clinical pharmacology in PCOs.
Dumitrescu, R., Mehedințu, C., Briceag, I., Purcărea, V. L., & Hudita, D. (2015) · PubMed · Cited by 62
Effect of Serotonin Transporter 5-HTTLPR Polymorphism on Gastrointestinal Intolerance to Metformin: A GoDARTS Study
Dujić, T., Zhou, K., Tavendale, R., Palmer, C. N. A., & Pearson, E. R. (2016) · Diabetes Care · doi:10.2337/dc16-0706 · Cited by 56
In Vitro Anti-Echinococcal and Metabolic Effects of Metformin Involve Activation of AMP-Activated Protein Kinase in Larval Stages of Echinococcus granulosus
Loos, J. A., & Cumino, A. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126009 · Cited by 55
Metformin, an Old Drug, Brings a New Era to Cancer Therapy
He, H., Ke, R., Lin, H., Ying, Y., Liu, D., & Luo, Z. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000103 · Cited by 55
Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in AMPK-dependent manner in rat primary microglia
Łabuzek, K., Liber, S., Gabryel, B., Adamczyk, J., & Okopień, B. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-009-0477-x · Cited by 55
Differential effects of metformin on bile salt absorption from the jejunum and ileum
Carter, D., Howlett, H. C. S., Wiernsperger, N. F., & Bailey, C. J. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00252.x · Cited by 54
Self-citation
Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathways
Zamanian, M. Y., Golmohammadi, M., Yumashev, A., Hjazi, A. M., Toama, M. A., AbdRabou, M. A., Gehlot, A., Alwaily, E. R., Shirsalimi, N., Yadav, P. K., et al. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4071 · Cited by 53
Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells
Berstein, L. M., Yue, W., Wang, J., & Santen, R. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1072-z · Cited by 55
Metformina – mechanizmy działania i zastosowanie w terapii cukrzycy typu 2[i][/i]
Grzybowska, M., Bober, J., & Olszewska, M. (2011) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.941655 · Cited by 52
Metformin Inhibits Androgen-Induced IGF-IR Up-Regulation in Prostate Cancer Cells by Disrupting Membrane-Initiated Androgen Signaling
Malaguarnera, R., Sacco, A., Morcavallo, A., Squatrito, S., Migliaccio, A., Morrione, A., Maggiolini, M., & Belfiore, A. (2014) · Endocrinology · doi:10.1210/en.2013-1925 · Cited by 50
Prediction and validation of enzyme and transporter off-targets for metformin
Yee, S. W., Lin, L., Merski, M., Keiser, M. J., Gupta, A., Zhang, Y., Chien, H., Shoichet, B. K., & Giacomini, K. M. (2015) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-015-9436-y · Cited by 49
Physiologically based metformin pharmacokinetics model of mice and scale-up to humans for the estimation of concentrations in various tissues
Zake, D. M., Kurlovičs, J., Zaharenko, L., Komašilovs, V., Kloviņš, J., & Stalidzāns, E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249594 · Cited by 50
Effects of metformin on SGLT1, GLUT2, and GLUT5 hexose transporter gene expression in small intestine from rats
Lenzen, S., Lortz, S., & Tiedge, M. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02243-0 · Cited by 48
Increased F-18 FDG Intestinal Uptake in Diabetic Patients on Metformin
Bybel, B., Greenberg, I. D., Paterson, J., Ducharme, J., & Leslie, W. D. (2011) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e318217399e · Cited by 47
Unexpectedly long half‐life of metformin elimination in cases of metformin accumulation
Kajbaf, F., Bennis, Y., Hurtel‐Lemaire, A., Andréjak, M., & Lalau, J. D. (2015) · Diabetic Medicine · doi:10.1111/dme.12959 · Cited by 47
Metformin exhibits preventive and therapeutic efficacy against experimental cystic echinococcosis
Loos, J. A., Dávila, V. A., Rodrígues, C. R., Petrigh, R. S., Zoppi, J. A., Crocenzi, F. A., & Cumino, A. C. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005370 · Cited by 47
Inhibition of gluconeogenesis by vanadium and metformin in kidney-cortex tubules isolated from control and diabetic rabbits
Kiersztan, A., Modzelewska, A., Jarzyna, R., Jagielska, E., & Bryła, J. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00861-4 · Cited by 47
Pharmacogenetics and personalized treatment of type 2 diabetes
Semiz, S., Dujić, T., & Čaušević, A. (2013) · Biochemia Medica · doi:10.11613/bm.2013.020 · Cited by 46
Metformin: A Bridge between Diabetes and Prostate Cancer
Zingales, V., Distefano, A., Raffaele, M., Zanghì, A., Barbagallo, I. A., & Vanella, L. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00243 · Cited by 46
Metformin inhibits β-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells
Amable, G., Martínez-León, E., Picco, M. E., Siervi, N. D., Davio, C. A., Rozengurt, E., & Rey, O. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.05.004 · Cited by 47
Attenuation of hepatic expression and secretion of selenoprotein P by metformin
Speckmann, B., Sies, H., & Steinbrenner, H. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.143 · Cited by 46
Anticancer effects of metformin on neuroendocrine tumor cells in vitro
Vlotides, G., Tanyeri, A., Spampatti, M. P., Zitzmann, K., Chourdakis, M., Spöttl, G., Maurer, J., Nölting, S., Göke, B., & Auernhammer, C. J. (2014) · HORMONES · doi:10.14310/horm.2002.1517 · Cited by 47
Does the antidiabetic drug metformin affect embryo development and the health of brown trout (Salmo trutta f. fario)?
Jacob, S., Dötsch, A., Knoll, S., Köhler, H., Rogall, E. T., Stoll, D., Tisler, S., Hühn, C., Schwartz, T., Zwiener, C., et al. (2018) · Environmental Sciences Europe · doi:10.1186/s12302-018-0179-4 · Cited by 49
Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy
Yue, W., Wang, T., Zachariah, E., Lin, Y., Yang, C. S., Xu, Q., DiPaola, R. S., & Tan, X. (2015) · Scientific Reports · doi:10.1038/srep13390 · Cited by 43
Effect of Metformin on Viability, Morphology, and Ultrastructure of Mouse Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells and Balb/3T3 Embryonic Fibroblast Cell Line
Śmieszek, A., Czyrek, A. A., Basińska, K., Trynda, J., Skaradzińska, A., Siudzińska, A., Marędziak, M., & Marycz, K. (2015) · BioMed Research International · doi:10.1155/2015/769402 · Cited by 42
Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2
Seliger, C., Meyer, A.-L., Renner, K., Leidgens, V., Moeckel, S., Jachnik, B., Dettmer, K., Tischler, U., Gerthofer, V., Rauer, L., et al. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1186316 · Cited by 42
Metformin causes a futile intestinal–hepatic cycle which increases energy expenditure and slows down development of a type 2 diabetes-like state
Schommers, P., Thurau, A., Bultmann-Mellin, I., Guschlbauer, M., Klatt, A. R., Rozman, J., Klingenspor, M., de Angelis, M. H., Alber, J., Gründemann, D., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.05.002 · Cited by 42
The Gut Microbiota-Related Antihyperglycemic Effect of Metformin
Szymczak-Pajor, I., Drzewoski, J., Kozłowska, M., Krekora, J., & Śliwińska, A. (2025) · Pharmaceuticals · doi:10.3390/ph18010055 · Cited by 43
Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells
Bruno, S., Ledda, B., Tenca, C., Ravera, S., Orengo, A. M., Mazzarello, A. N., Pesenti, E., Casciaro, S., Racchi, O., Ghiotto, F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4168 · Cited by 42
Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species
Jeong, Y., & Jusko, W. J. (2021) · Pharmaceuticals · doi:10.3390/ph14060545 · Cited by 43
Pharmacodynamic–pharmacokinetic profiles of metformin hydrochloride from a mucoadhesive formulation of a polysaccharide with antidiabetic property in streptozotocin-induced diabetic rat models
Adikwu, M. U., Yoshikawa, Y., & Takada, K. (2003) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.073 · Cited by 41
Metformin as a new anti-cancer drug in adrenocortical carcinoma
Poli, G., Cantini, G., Armignacco, R., Fucci, R., Santi, R., Canu, L., Nesi, G., Mannelli, M., & Luconi, M. (2016) · Oncotarget · doi:10.18632/oncotarget.10421 · Cited by 40
Biphasic effect of metformin on human cardiac energetics
Emelyanova, L. V., Bai, X., Yan, Y., Bosnjak, Z. J., Kress, D. C., Warner, C., Kroboth, S., Rudic, T., Kaushik, S., Stoeckl, E. M., et al. (2020) · Translational research · doi:10.1016/j.trsl.2020.10.002 · Cited by 41
Metformin: Metabolic Rewiring Faces Tumor Heterogeneity
Cioce, M., Pulito, C., Strano, S., Blandino, G., & Fazio, V. M. (2020) · Cells · doi:10.3390/cells9112439 · Cited by 41
Metformin Synergistically Potentiates the Antitumor Effects of Imatinib in Colorectal Cancer Cells
Lee, J., Park, D., & Lee, Y. (2017) · Development & Reproduction · doi:10.12717/dr.2017.21.2.139 · Cited by 40
Modulatory role of gut microbiota in cholesterol and glucose metabolism: Potential implications for atherosclerotic cardiovascular disease
Roessler, J., Leistner, D. M., Landmesser, U., & Haghikia, A. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.08.018 · Cited by 39
Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations
Meyer, M. J., Tuerkova, A., Römer, S., Wenzel, C., Seitz, T., Gaedcke, J., Oswald, S., Brockmöller, J., Zdrazil, B., & Tzvetkov, M. V. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000170 · Cited by 38
Metformin (dimethyl-biguanide) induced DNA damage in mammalian cells
Amador, R. R., Longo, J. P. F., Lacava, Z. G. M., Dórea, J. G., & Santos, M. D. F. M. A. (2011) · Genetics and Molecular Biology · doi:10.1590/s1415-47572011005000060 · Cited by 37
The Interplay of AMP-Activated Protein Kinase and Androgen Receptor in Prostate Cancer Cells
Shen, M., Zhang, Z., Ratnam, M., & Dou, Q. P. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24494 · Cited by 37

Authors: Wilcock, C., & Bailey, C. J.
Affiliations: Aston University (GB)
ORCID: Bailey, C. J.
Venue: Xenobiotica
Publisher: Informa UK Limited
Published: 1994-01
Volume: 24
Issue: 1
Pages: 49-57
ISSN: 0049-8254 (ISSN-L)
1366-5928
DOI: 10.3109/00498259409043220
OpenAlex: W2136667764
Cited by: 418
References: 23
Citations by year: 2026: 6 · 2025: 14 · 2024: 20 · 2023: 23 · 2022: 22 · 2021: 23 · 2020: 21 · 2019: 24 · 2018: 30 · 2017: 31 · 2016: 26 · 2015: 31 · 2014: 30 · 2013: 19 · 2012: 12
FWCI: 2.92
Type: journal article
Language: en
Open access: closed
Locations: Xenobiotica (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: metformin, tissue accumulation, streptozotocin-induced diabetes, small intestine, drug retention, plasma concentration, oral administration, antidiabetic drugs, drug distribution
MeSH terms: Administration, Oral, Animals, Diabetes Mellitus, Experimental, Digestive System, Injections, Intravenous, Male, Metformin, Mice, Inbred Strains, Tissue Distribution, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Accumulation of metformin by tissues of the normal and diabetic mouse

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks